Collaboration Details

Print  Close


Title of Collaborative Activity:

Preclinical Assessment of Phage Therapy for Pathogen Decolonization

Description of Collaborative Activity:

This project addresses key regulatory considerations relevant to using bacteriophages for decolonization of the drug-resistant nosocomial pathogens, vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA). These include characterizing pathogen resistance to phage, defining phage mixtures ("cocktails") to circumvent resistance, optimizing mouse models to evaluate pathogen decolonization, and identifying endpoints that support claims for clinical benefit (e.g., reduced risk of disease transmission).

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2015

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

FDA